UNIVERSITY COLLEGE LONDON
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1826-02-11
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ucl.ac.uk
RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local Surgery
- Conditions
- Gastrointestinal ComplicationsProstate CancerSexual DysfunctionUrinary Complications
- Interventions
- Procedure: adjuvant therapyProcedure: quality-of-life assessmentRadiation: radiation therapy
- First Posted Date
- 2007-10-08
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- University College, London
- Target Recruit Count
- 4236
- Registration Number
- NCT00541047
- Locations
- 🇨🇦
London Regional Cancer Program at London Health Sciences Centre, London, Ontario, Canada
🇨🇦Ottawa Health Research Institute, Ottawa, Ontario, Canada
🇬🇧Lincoln County Hospital, Lincoln, England, United Kingdom
Screening for Lung Cancer in Current or Past Smokers With Chronic Obstructive Pulmonary Disease
- Conditions
- Lung CancerPrecancerous Condition
- Interventions
- Other: cytology and cytometry specimen collection procedureOther: Chest x rayProcedure: Autofluorescence bronchoscopyProcedure: CT scan
- First Posted Date
- 2007-08-08
- Last Posted Date
- 2011-12-21
- Lead Sponsor
- University College, London
- Target Recruit Count
- 1569
- Registration Number
- NCT00512746
- Locations
- 🇬🇧
University Hospitals of Leicester NHS Trust, Leicester, England, United Kingdom
🇬🇧Chelsea Westminster Hospital, London, England, United Kingdom
🇬🇧University College Hospital - London, London, England, United Kingdom
Biliary Stenting With or Without Photodynamic Therapy in Treating Patients With Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors That Cannot Be Removed by Surgery
- Conditions
- Extrahepatic Bile Duct CancerGallbladder Cancer
- Interventions
- Procedure: biliary stenting
- First Posted Date
- 2007-08-08
- Last Posted Date
- 2013-02-20
- Lead Sponsor
- University College, London
- Target Recruit Count
- 92
- Registration Number
- NCT00513539
- Locations
- 🇬🇧
Aintree University Hospital, Liverpool, England, United Kingdom
🇬🇧Ninewells Hospital, Dundee, Scotland, United Kingdom
🇬🇧University College Hospital, London, England, United Kingdom
Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2007-02-12
- Last Posted Date
- 2014-12-03
- Lead Sponsor
- University College, London
- Target Recruit Count
- 846
- Registration Number
- NCT00433498
- Locations
- 🇬🇧
Walsall Manor Hospital, Walsall, England, United Kingdom
🇬🇧Weston General Hospital, Weston-super-Mare, England, United Kingdom
🇬🇧Addenbrooke's Hospital, Cambridge, England, United Kingdom
High Dose vs Low Dose I 131 +/- rhTSH for Differentiated Thyroid Cancer
- Conditions
- Head and Neck Cancer
- Interventions
- Biological: recombinant thyroid-stimulating hormoneRadiation: Radiodine ablation without rhTSH
- First Posted Date
- 2006-12-22
- Last Posted Date
- 2023-12-19
- Lead Sponsor
- University College, London
- Target Recruit Count
- 438
- Registration Number
- NCT00415233
- Locations
- 🇬🇧
Leicester Royal Infirmary, Leicester, England, United Kingdom
🇬🇧Royal Marsden - London, London, England, United Kingdom
🇬🇧Northampton General Hospital, Northampton, England, United Kingdom
Cisplatin, Vinorelbine, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
- Conditions
- Lung Cancer
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2014-12-03
- Lead Sponsor
- University College, London
- Target Recruit Count
- 130
- Registration Number
- NCT00309972
- Locations
- 🇬🇧
Clatterbridge Centre for Oncology, Merseyside, England, United Kingdom
Low-Dose Radiation Therapy in Treating Patients With Follicular or Marginal Zone Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- Radiation: radiation therapy
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2017-11-17
- Lead Sponsor
- University College, London
- Target Recruit Count
- 614
- Registration Number
- NCT00310167
- Locations
- 🇬🇧
Cancer Research UK and University College London Cancer Trials Centre, London, England, United Kingdom
Prostate Adenocarcinoma TransCutaneous Hormones
- Conditions
- Hot FlashesAnemiaOsteoporosisProstate CancerCardiovascular Complications
- Interventions
- First Posted Date
- 2006-03-17
- Last Posted Date
- 2020-11-27
- Lead Sponsor
- University College, London
- Target Recruit Count
- 2200
- Registration Number
- NCT00303784
- Locations
- 🇬🇧
Walsgrave Hospital, Coventry, England, United Kingdom
🇬🇧Mayday University Hospital, Croydon, England, United Kingdom
🇬🇧Kidderminster Hospital, Kidderminster Worcestershire, England, United Kingdom
CMV Glycoprotein B Vaccine in Allograft Recipients
- Conditions
- Cytomegalovirus Infections
- Interventions
- Biological: CMV gB vaccineDrug: Placebo
- First Posted Date
- 2006-03-06
- Last Posted Date
- 2010-04-19
- Lead Sponsor
- University College, London
- Target Recruit Count
- 140
- Registration Number
- NCT00299260
- Locations
- 🇬🇧
University College Medical School, London, United Kingdom
Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- Drug: Matched placebo
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2014-12-03
- Lead Sponsor
- University College, London
- Target Recruit Count
- 670
- Registration Number
- NCT00275132
- Locations
- 🇬🇧
London Lung Cancer Group, London, England, United Kingdom